Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/32945
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hopwood, J. | - |
dc.date.issued | 2001 | - |
dc.identifier.citation | Journal of Inherited Metabolic Disease, 2001; 24(SUPPL. 2):45-46 | - |
dc.identifier.issn | 0141-8955 | - |
dc.identifier.issn | 1573-2665 | - |
dc.identifier.uri | http://hdl.handle.net/2440/32945 | - |
dc.language.iso | en | - |
dc.publisher | Kluwer Academic Publ | - |
dc.rights | © 2001 SSIEM and Kluwer Academic Publishers | - |
dc.source.uri | http://dx.doi.org/10.1023/a:1012459521922 | - |
dc.title | Selection of endpoints in clinical studies of enzyme replacement therapy in lysosomal storage disorders - Commentary | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1023/A:1012459521922 | - |
pubs.publication-status | Published | - |
Appears in Collections: | Aurora harvest 6 Paediatrics publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.